Huize Holding, a Shanghai-based insurance platform backed by SAIF Partners, has raised about $55 million in a US IPO.
The company sold 5.3 million American depository shares (ADSs) at $10.50 apiece, the midpoint of the indicative range, according to a filing. The stock opened at $10.65 on February 12 and closed down 4.75%...
Suzhou Medilink Therapeutics, a Chinese biotech company specializing in antibody-drug conjugates (ADCs) commonly used as targeted therapies for treating cancer, has raised $50 million in Series A funding across two tranches.
OrbiMed has closed its latest Asia life sciences fund, which primarily invests in China and India, with $800 million in commitments.
Tuya, a Chinese software platform for internet-of-things (IoT) systems that mainly offers platform-as-a-service (PaaS) products is pursuing a US IPO.